Fidelity Investments
KURA icon

Fidelity Investments’s Kura Oncology KURA Stock Holding History

Fidelity Investments’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.58M Buy
317,652
+11,050
+4% +$94.9K ﹤0.01% 2552
2025
Q4 		$3.19M Buy
306,602
+219,728
+253% +$2.31M ﹤0.01% 2437
2025
Q3 		$769K Buy
86,874
+41,673
+92% +$297K ﹤0.01% 2895
2025
Q2 		$261K Buy
45,201
+32,113
+245% +$197K ﹤0.01% 3211
2025
Q1 		$86.4K Sell
13,088
-171,340
-93% -$1.34M ﹤0.01% 3622
2024
Q4 		$1.61M Buy
184,428
+97,997
+113% +$1.41M ﹤0.01% 2513
2024
Q3 		$1.69M Buy
86,431
+17,913
+26% +$363K ﹤0.01% 2448
2024
Q2 		$1.41M Buy
68,518
+3,845
+6% +$79K ﹤0.01% 2431
2024
Q1 		$1.38M Buy
64,673
+199
+0.3% +$3.87K ﹤0.01% 2426
2023
Q4 		$927K Sell
64,474
-6,005
-9% -$59K ﹤0.01% 2495
2023
Q3 		$643K Buy
70,479
+4,315
+7% +$43.8K ﹤0.01% 2568
2023
Q2 		$700K Buy
66,164
+25,325
+62% +$300K ﹤0.01% 2564
2023
Q1 		$499K Buy
40,839
+1,481
+4% +$18.5K ﹤0.01% 2692
2022
Q4 		$488K Sell
39,358
-27,465
-41% -$399K ﹤0.01% 2726
2022
Q3 		$913K Buy
66,823
+553
+0.8% +$8.53K ﹤0.01% 2632
2022
Q2 		$1.21M Sell
66,270
-278
-0.4% -$4K ﹤0.01% 2625
2022
Q1 		$1.07M Sell
66,548
-5,515,652
-99% -$79.6M ﹤0.01% 2774
2021
Q4 		$78.2M Sell
5,582,200
-642,573
-10% -$10.4M 0.01% 1220
2021
Q3 		$117M Sell
6,224,773
-1,579,202
-20% -$29.8M 0.01% 1034
2021
Q2 		$163M Sell
7,803,975
-1,375,494
-15% -$34.1M 0.01% 901
2021
Q1 		$260M Buy
9,179,469
+63,429
+0.7% +$2.01M 0.02% 673
2020
Q4 		$298M Buy
9,116,040
+1,876,852
+26% +$66M 0.03% 582
2020
Q3 		$222M Sell
7,239,188
-845,495
-10% -$18.7M 0.02% 599
2020
Q2 		$132M Buy
8,084,683
+1,270,477
+19% +$18.3M 0.01% 764
2020
Q1 		$67.8M Buy
6,814,206
+17,004
+0.3% +$195K 0.01% 918
2019
Q4 		$93.5M Buy
6,797,202
+64,213
+1% +$951K 0.01% 938
2019
Q3 		$102M Buy
6,732,989
+1,862,111
+38% +$33.1M 0.01% 878
2019
Q2 		$95.9M Buy
4,870,878
+3,024,868
+164% +$50.2M 0.01% 933
2019
Q1 		$30.6M Sell
1,846,010
-439,500
-19% -$6.77M ﹤0.01% 1411
2018
Q4 		$32.1M Hold
2,285,510
– – ﹤0.01% 1363
2018
Q3 		$40M Sell
2,285,510
-1,080,909
-32% -$20.7M ﹤0.01% 1375
2018
Q2 		$61.3M Sell
3,366,419
-1,067,096
-24% -$18.1M 0.01% 1183
2018
Q1 		$83.1M Buy
4,433,515
+2,352,344
+113% +$45.8M 0.01% 1060
2017
Q4 		$31.8M Sell
2,081,171
-505,748
-20% -$7.45M ﹤0.01% 1508
2017
Q3 		$38.7M Sell
2,586,919
-229,000
-8% -$2.15M ﹤0.01% 1422
2017
Q2 		$26.2M Hold
2,815,919
– – ﹤0.01% 1566
2017
Q1 		$24.8M Hold
2,815,919
– – ﹤0.01% 1605
2016
Q4 		$16.6M Hold
2,815,919
– – ﹤0.01% 1758
2016
Q3 		$17.6M Hold
2,815,919
– – ﹤0.01% 1737
2016
Q2 		$7.63M Sell
2,815,919
-281,435
-9% -$875K ﹤0.01% 2073
2016
Q1 		$12.5M Sell
3,097,354
-16,365
-0.5% -$77.6K ﹤0.01% 1859
2015
Q4 		$26.2M Buy
+3,113,719
New +$24.5M ﹤0.01% 1557

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments's KURA Position: Q1 2026 in Review

Fidelity Investments increased its Kura Oncology (KURA) stake by 3.6% in Q1 2026, buying an estimated $94.9K and bringing the position to 317,652 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2552.

Fidelity Investments first reported a position in KURA in Q4 2015 and has held it in 42 quarters since. The position peaked at $298M in Q4 2020. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Fidelity Investments held 317,652 shares of Kura Oncology worth $2.58M as of Q1 2026.
  • Fidelity Investments bought 11,050 Kura Oncology shares in Q1 2026, an estimated $94.9K.
  • Kura Oncology made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2552 holding.
  • Fidelity Investments first reported a position in Kura Oncology in Q4 2015 and has held it in 42 quarters since.
  • Fidelity Investments's Kura Oncology position peaked at $298M in Q4 2020.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.